Analysis of Dental Patient Care America, Inc. (DPAT)
Dental Patient Care America, Inc. (DPAT) has shown some interesting price movements and technical indicators in the recent days:
1. Price Movement: The closing price has been relatively stable around 0.00620 in the past few days, with a slight increase to 0.01000 on the most recent day. This could indicate some potential price stability or a possible uptrend.
2. RSI Indicator: The Relative Strength Index (RSI) has been around 25.62 in the past few days, indicating that the stock may have been oversold. The recent increase in RSI to 54.35 could suggest a shift towards a more bullish sentiment.
3. MACD Indicator: The Moving Average Convergence Divergence (MACD) indicator has been negative in the past days, but the MACD histogram has shown a slight increase towards the positive territory. This could be a sign of a potential bullish reversal.
4. Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating a possible convergence and a potential trend reversal.
Overall, based on the recent price movements and technical indicators, Dental Patient Care America, Inc. (DPAT) could be showing signs of a potential bullish reversal. However, it is important to consider other factors and conduct further analysis before making any investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin, operating margin, return on assets, and return on equity are all at healthy levels. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has a beta of 1.264 and has shown a slight increase in the fifty-two week period.
Valuation metrics show a relatively high PEG ratio and forward PE ratio, with the company's market capitalization and enterprise value also being substantial. The price to book and price to sales ratios are on the higher side, while the enterprise to EBITDA and enterprise to revenue ratios are at moderate levels.
The stock price summary includes key metrics such as the 50-day and 200-day moving averages, as well as the fifty-two week low and high prices.
Lastly, the dividends and splits information shows details about the company's dividend payments, dividend yield, and historical split events.
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been fluctuating, with a peak in 2021 at $152.8 billion and a slight decrease in 2023 to $169.1 billion.
3. Operating income has shown an overall increasing trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has also been on the rise, with a significant increase from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years, indicating growth in profitability per share.
6. The company has been able to maintain a stable diluted shares outstanding count over the years, which is important for calculating various financial ratios.
7. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:
1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. Current assets fluctuate from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have also been increasing steadily, with the highest value in 2019 at $234,386,000,000.
4. Total liabilities have been increasing, reaching the highest value of $302,083,000,000 in 2022.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current liabilities to finance its operations, as seen in the increasing trend over the years.
7. The company has been investing more in non-current assets, such as investments and advances, machinery, furniture, and equipment, which indicates potential long-term growth strategies.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, long-term debt issuance, and payments, with significant fluctuations in these values.
6. Investing activities indicate a mix of acquisitions, investments, and capital expenditures, with varying levels of cash flow from these activities each year.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing growth compared to the year-ago EPS figures, indicating optimism among analysts regarding the company's performance.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience solid growth over the next few years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions regarding the future price of the security, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price of the security is $191.57, which is below the median and average forecast, indicating that there is potential for the price to increase according to the analysts' predictions.MACD of DPAT